Ex-billionaire prepares to launch animal drugs

A PUBLICLY-listed company chaired by former billionaire and bankrupt Kevin Leech is to split into two separate public companies to allow the animal division to focus on taking two 'potential blockbuster' products to a world market valued at US$18 billion.


Coutts sponsors Durrell scheme

TEENAGERS interested in conservation have been given a financial boost by a Jersey investment firm.